1JNX | X:1649-1757; X:1758-1859 | CRYSTAL STRUCTURE OF THE BRCT REPEAT REGION FROM THE BREAST CANCER ASSOCIATED PROTEIN, BRCA1 |
1N5O | X:1649-1757; X:1758-1859 | STRUCTURAL CONSEQUENCES OF A CANCER-CAUSING BRCA1-BRCT MISSENSE MUTATION |
1OQA | A: | SOLUTION STRUCTURE OF THE BRCT-C DOMAIN FROM HUMAN BRCA1 |
1T15 | A:1649-1757; A:1758-1859 | CRYSTAL STRUCTURE OF THE BRCA1 BRCT DOMAINS IN COMPLEX WITH THE PHOSPHORYLATED INTERACTING REGION FROM BACH1 HELICASE |
1T29 | A:1649-1757; A:1758-1859 | CRYSTAL STRUCTURE OF THE BRCA1 BRCT REPEATS BOUND TO A PHOSPHORYLATED BACH1 PEPTIDE |
1T2U | A:1649-1757; A:1758-1859 | STRUCTURAL BASIS OF PHOSPHOPEPTIDE RECOGNITION BY THE BRCT DOMAIN OF BRCA1: STRUCTURE OF BRCA1 MISSENSE VARIANT V1809F |
1T2V | A:1649-1757; A:1758-1859; B:1646-1757; B:1758-1859; C:1649-1757; C:1758-1859; D:1647-1757; D:1758-1856; E:1649-1757; E:1758-1859 | STRUCTURAL BASIS OF PHOSPHO-PEPTIDE RECOGNITION BY THE BRCT DOMAIN OF BRCA1, STRUCTURE WITH PHOSPHOPEPTIDE |
1Y98 | A:1650-1756; A:1760-1855 | STRUCTURE OF THE BRCT REPEATS OF BRCA1 BOUND TO A CTIP PHOSPHOPEPTIDE. |
2ING | X:1650-1756; X:1760-1855 | X-RAY STRUCTURE OF THE BRCA1 BRCT MUTANT M1775K |
3COJ | A:1650-1756; A:1760-1855; B:1650-1756; B:1760-1855; C:1650-1756; C:1760-1855; D:1650-1756; D:1760-1855; E:1650-1756; E:1760-1855; F:1650-1756; F:1760-1855; G:1650-1756; G:1760-1855; X:1650-1756; X:1760-1855 | CRYSTAL STRUCTURE OF THE BRCT DOMAINS OF HUMAN BRCA1 IN COMPLEX WITH A PHOSPHORYLATED PEPTIDE FROM HUMAN ACETYL-COA CARBOXYLASE 1 |
3PXA | A:1649-1757; A:1758-1859 | IMPACT OF BRCA1 BRCT DOMAIN MISSENSE SUBSTITUTIONS ON PHOSPHO-PEPTIDE RECOGNITION: G1656D |
3PXB | A:1649-1757; A:1758-1859 | IMPACT OF BRCA1 BRCT DOMAIN MISSENSE SUBSTITUTIONS ON PHOSPHO-PEPTIDE RECOGNITION: T1700A |
3PXC | X:1649-1757; X:1758-1859 | IMPACT OF BRCA1 BRCT DOMAIN MISSENSE SUBSTITUTIONS ON PHOSPHO-PEPTIDE RECOGNITION: R1699Q |
3PXD | A:1649-1757; A:1758-1859 | IMPACT OF BRCA1 BRCT DOMAIN MISSENSE SUBSTITUTIONS ON PHOSPHO-PEPTIDE RECOGNITION: R1835P |